Far UV Technologies chosen by BARDA

November 3, 2021 – Far UV was chosen by BARDA (the Biomedical Advanced Research and Development Authority, a U.S. Department of Health and Human Services) to present a Lightning Talk at the BARDA Industry Day

Latest News

Far UV Continues to Help the ImmunocompromisedDecember 6, 2023 - 10:11 am
Far UV Technologies Krypton Lighting and AeroMed Upper Room Solutions Now Available Globally for Rapid Deployment for Transportation and More Via Boeing Wholesale DistributionNovember 13, 2023 - 10:43 am
ASHRAE Approves Groundbreaking Standard to Reduce the Risk of Disease Transmission in Indoor SpacesJune 24, 2023 - 4:13 pm

*All references to “disinfection” are referring generally to reduction of bioburden and are not intended to refer to any specific definition of the term as may be used for other purposes by the U.S. Food and Drug Administration or the U.S. Environmental Protection Agency. The disinfection technology as incorporated in Far UV Technologies products is not intended for use in the cure, mitigation or prevention of disease and is not certified or approved for use as or for the disinfection of medical devices by the FDA. Bioburden reduction is a function of fixture run time, distance to the UV light source, air flow, room size, shadow areas and/or other factors, and the level of reduction will vary within a specific space.

November 3, 2021 – Far UV was chosen by BARDA (the Biomedical Advanced Research and Development Authority, a U.S. Department of Health and Human Services) to present a Lightning Talk at the BARDA Industry Day

Headquarters

Latest News